US medical company Tempus, valued at over $3 billion, have also partnered with LINK to launch their AI genomic tests in the UK. Nice indication for Rhythm investors that LINK is a 'go-to' organisation.
Tempus appear to be powering along in the US, they recently gained pre-approval for an FDA application. They also have a collaboration with Pfizer, plus an office in South Africa, interesting!
Check out the news updates on their website.
- Forums
- ASX - By Stock
- Ann: UK Strategic Partnership with LINK Medical Solutions
US medical company Tempus, valued at over $3 billion, have also...
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
6.5¢ |
Change
-0.002(2.99%) |
Mkt cap ! $16.15M |
Open | High | Low | Value | Volume |
6.5¢ | 6.5¢ | 6.5¢ | $4.305K | 66.23K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 178635 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 1128 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 178635 | 0.065 |
2 | 110864 | 0.064 |
1 | 131025 | 0.063 |
2 | 15000 | 0.062 |
3 | 59180 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 1128 | 1 |
0.069 | 51260 | 1 |
0.070 | 86753 | 4 |
0.071 | 150525 | 1 |
0.072 | 2245 | 1 |
Last trade - 10.35am 25/06/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |